Company Filing History:
Years Active: 2017
Title: Hisham Omer Eissa: Innovator in Tankyrase Inhibition
Introduction
Hisham Omer Eissa is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit tankyrase enzymes. His work is crucial for advancing therapeutic options in various diseases.
Latest Patents
Hisham Omer Eissa holds a patent for Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors. This patent includes formulations containing these compounds and their use as inhibitors for tankyrase 1 and 2. The innovative formula is designated as Formula (I). This patent showcases his expertise in creating effective pharmaceutical compounds.
Career Highlights
Eissa is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development of new therapeutic agents. His work has contributed to the company's mission of improving patient outcomes through innovative medicines.
Collaborations
Hisham has collaborated with esteemed colleagues such as Marcio Chedid and Thomas Albert Engler. These partnerships have enhanced the research efforts and have led to advancements in their shared field of study.
Conclusion
Hisham Omer Eissa is a prominent figure in the realm of medicinal chemistry, with a focus on tankyrase inhibitors. His contributions through patents and collaborations reflect his commitment to innovation in healthcare.